BBI to make Verax Platelet PGD tests
This article was originally published in Clinica
Executive Summary
Verax Biomedical, the Worcester, Massachusetts developer of rapid bacterial testing technology, has signed a 10-year deal under which British Biocell International (BBI) could make up to 50 million units of the Verax Platelet PGD test.